Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 6
2005 7
2006 4
2007 4
2008 4
2009 3
2010 5
2011 3
2012 6
2013 2
2014 2
2015 10
2016 8
2017 2
2018 2
2019 7
2020 22
2021 22
2022 40
2023 37
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hyung wook kim (287 results)?
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Tuberculosis: Republic of Korea, 2021.
Min J, Kim HW, Kim JS. Min J, et al. Among authors: kim hw. Tuberc Respir Dis (Seoul). 2023 Jan;86(1):67-69. doi: 10.4046/trd.2022.0111. Epub 2022 Oct 25. Tuberc Respir Dis (Seoul). 2023. PMID: 36281544 Free PMC article. No abstract available.
Coronary Artery Calcification Score and the Progression of Chronic Kidney Disease.
Yun HR, Joo YS, Kim HW, Park JT, Chang TI, Son NH, Yoo TH, Kang SW, Sung S, Lee KB, Lee J, Oh KH, Han SH; KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) investigators; KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). Yun HR, et al. Among authors: kim hw. J Am Soc Nephrol. 2022 Aug;33(8):1590-1601. doi: 10.1681/ASN.2022010080. Epub 2022 Jun 2. J Am Soc Nephrol. 2022. PMID: 35654602 Free PMC article.
Intrarenal Renin-Angiotensin System Activation Alters Relationship Between Systolic Blood Pressure and Progression of Chronic Kidney Disease.
Park CH, Kim HW, Park JT, Chang TI, Yoo TH, Lee J, Sung S, Jung JY, Hyun YY, Oh KH, Kang SW, Han SH; on the behalf of the KNOW-CKD (Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease) Investigators. Park CH, et al. Among authors: kim hw. Hypertension. 2023 May;80(5):1024-1034. doi: 10.1161/HYPERTENSIONAHA.122.20824. Epub 2023 Mar 28. Hypertension. 2023. PMID: 37075134
Plasma Levels of Polyunsaturated Fatty Acids and Adverse Kidney Outcomes.
Koh HB, Kim HW, Joo YS, Jung CY, Kim HJ, Chang TI, Park JT, Yoo TH, Kang SW, Han SH. Koh HB, et al. Among authors: kim hw. Am J Kidney Dis. 2024 Feb 28:S0272-6386(24)00622-X. doi: 10.1053/j.ajkd.2023.12.020. Online ahead of print. Am J Kidney Dis. 2024. PMID: 38423161
202 results